| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:309690888:2841 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:309690888:2841?format=raw |
LEADER: 02841cam a22003258a 4500
001 4269506
005 20221102192757.0
008 030815s2004 nyu 000 0 eng
015 $aGBA3-V1470
020 $a0824740297
035 $a(OCoLC)54689684
035 $a(OCoLC)ocm54689684
035 $a(NNC)4269506
035 $a4269506
040 $aUKM$cUKM$dCOU$dNNC-M$dOrLoB-B
082 04 $a616.24061$221
245 00 $aPharmacotherapy in chronic obstructive pulmonary disease /$cedited by Bartolome R. Celli.
260 $aNew York :$bMarcel Dekker ;$aLondon :$bMomenta,$c2004.
300 $axvii, 354 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aLung biology in health and disease ;$v182
505 00 $tIntroduction /$rClaude Lenfant -- $gPt. 1.$tThe Application of Clinical Assessment to the Drug Development Process -- $g1.$tProviding Evidence of Therapeutic Benefit in Clinical Drug Development /$rSteven Kesten and Theodore J. Witek -- $gPt. 2.$tMeasuring Outcomes -- $g2.$tUse of Expiratory Airflows and Lung Volumes to Assess Outcomes in COPD /$rGary T. Ferguson -- $g3.$tExercise Testing /$rDenis E. O'Donnell and Katherine A. Webb -- $g4.$tSleep-Related Breathing Disturbances in COPD /$rWalter T. McNicholas -- $g5.$tAirway and Alveolar Determinants of Airflow Limitation in COPD /$rNoe Zamel -- $g6.$tGas Exchange /$rAntoni Ferrer, Joan Albert Barbera and Roberto Rodriguez-Roisin -- $g7.$tGenetics of COPD /$rJian-Qing He, Ikuma Kasuga and Peter D. Pare -- $g8.$tDyspnea /$rDonald A. Mahler -- $g9.$tExacerbations of COPD /$rJadwiga A. Wedzicha -- $g10.$tHealth Status Measurement in COPD /$rPaul W. Jones -- $g11.$tHealth Resource Utilization /$rMitchell Friedman -- $gPt. 3.$tSpecific Therapy -- $g12.$tAnticholinergics /$rPeter J. Barnes -- $g13.$t[beta]-Adrenergic Receptor Agonist Bronchodilators in the Treatment of COPD /$rStephen I. Rennard -- $g14.$tTheophylline and Phosphodiesterase Inhibitors in COPD /$rAlicia R. ZuWallack and Richard L. ZuWallack -- $g15.$tCorticosteroids in COPD /$rMario Cazzola, Maria Gabriella Matera and Romain Pauwels -- $g16.$tAntioxidants and Protease Inhibitors /$rMario Cazzola and Maria Gabriella Matera -- $g17.$tAn Integrated Approach to the Pharmacological Therapy of COPD /$rBartolome R. Celli.
650 0 $aLungs$xDiseases, Obstructive$xChemotherapy.
650 12 $aPulmonary Disease, Chronic Obstructive.$0https://id.nlm.nih.gov/mesh/D029424
650 12 $aPulmonary Disease, Chronic Obstructive$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D029424Q000188
650 22 $aDrug Evaluation.$0https://id.nlm.nih.gov/mesh/D004341
700 1 $aCelli, Bartolome R.$0http://id.loc.gov/authorities/names/n00004603
830 0 $aLung biology in health and disease ;$vv. 182.
852 00 $boff,hsl$hRC776.O3$iP53 2004